Related Experiment Video
Updated: Nov 9, 2025
Modified MicroSecure Vitrification: A Safe, Simple and Highly Effective Cryopreservation Procedure for Human Blastocysts
Published on: March 2, 2017
Hyaluronic acid-enriched transfer medium for frozen embryo transfer: a randomized, double-blind, controlled trial
Sofie Shuk Fei Yung1, Shui Fan Lai2, Mei Ting Lam2
1Department of Obstetrics and Gynaecology, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People's Republic of China.
Objective:
To compare the effects of hyaluronic acid (HA)-enriched transfer medium versus standard medium on live birth rate after frozen embryo transfer (FET).
Design:
Randomized, double-blind, controlled trial.
Setting:
Two tertiary fertility centers.
Patient(S):
Infertile women aged <43 years at the time of in vitro fertilization undergoing FET.
Intervention(S):
The women were randomly assigned to 2 groups in a 1:1 ratio. The HA group used EmbryoGlue (Vitrolife, Gothenburg, Sweden) with an HA concentration of 0.5 mg/mL, while the control group used supplemented G-2 (Vitrolife) medium with an HA concentration of 0.125 mg/mL.
Main Outcome Measure(S):
Live birth rate.
Result(S):
Five hundred fifty women were recruited from April 2016 to April 2018 and included in the intention-to-treat analysis. Eight women in the HA group and 5 women in the control group did not undergo FET because the embryos did not survive on thawing. One woman in the HA group cancelled FET because of fever. One woman in the HA group withdrew and received conventional medium. The 2 groups were similar in demographic characteristics. The live birth rates in the HA group and the control group were comparable (25.5% vs. 25.8%; relative risk 0.99; 95% confidence interval 0.74-1.31). The other clinical outcomes were also similar between the 2 groups. Logistic regression showed that the type of transfer medium was not associated with live birth.
Conclusion(S):
The use of HA-enriched transfer medium does not improve the live birth rate of FET compared with standard medium.
Trial Registration Number:
NCT02725827 (ClinicalTrials.gov).
More Related Videos
07:02Minimally Invasive Embryo Transfer and Embryo Vitrification at the Optimal Embryo Stage in Rabbit Model
Published on: May 16, 2019
10:31Application of a Novel Hyaluronan Hydrogel for Three-Dimensional Follicle Culture and Methodology for Mouse Ovarian Follicle Cryopreservation
Published on: May 9, 2025
